Dataset: Molecular Classification of AIDS-Related Lymphomas [including third-party data]
[u'Gene expression profiling (GEP) of ARL patient samples was done to determine whether gene expression signatures derived from HIV-...
[u'Gene expression profiling (GEP) of ARL patient samples was done to determine whether gene expression signatures derived from HIV- lymphomas retained their ability to molecularly classify HIV+ lymphomas. The GEP-based predictors robustly classified ARL tumors, distinguishing molecular Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), as well as activated B-cell-like (ABC) and germinal center B-cell-like (GCB) molecular subtypes of DLBCL. Gene expression profiles were used to identify coordinately regulated gene sets and pathways that differ between HIV+ and HIV- lymphomas of corresponding molecular subtype. Frozen tumor biopsies were obtained from 20 HIV-positive patients with an AIDS-defining lymphoma. Cases were ascertained at the University of Nebraska Medical Center and through the NCI AIDS and Cancer Specimen Resource tumor bank. Sufficient RNA for hybridization to Affymetrix U133 plus 2 arrays was obtained on 17 ARL cases. Details of all 20 HIV-positive patients can be found in the supplementary file below. Third party array data from HIV- lymphomas of corresponding molecular subtype were used for the comparison and molecular classification of the HIV+ cases in this study. The third party HIV- lymphoma samples include the following. [1] HIV- lymphoma, BL cases: 84 samples profiled on the Affymetrix HG U133 Plus 2 array. The data are publicly available on the website companion to Dave et al. NEJM 2006; Volume 354:13-24 (', {u'a': {u'href': u'http://llmpp.nih.gov/BL/', u'target': u'_blank', u'$': u'http://llmpp.nih.gov/BL/'}}, u") and were used 'as is' (ie, not reanalyzed). [2] HIV- lymphoma, DLBCL cases: 200 of the 414 cases in Series GSE10846 (listed in the supplementary file below). These included all R-CHOP treated cases of either ABC or GCB subtype. These data were also used as is. These data were published in Lenz et al. NEJM 2008; Volume 359: 2313-2323."]
- Species:
- human
- Samples:
- 17
- Source:
- E-GEOD-17372
- PubMed:
- 20216076
- Updated:
- Dec.12, 2014
- Registered:
- Sep.12, 2014
Sample | AGE AT DIAGNOSIS | TUMOR BIOPSY ORIGIN | EBV STATUS | MOLECULAR DIAGNOSIS | PATHOLOGY DIAGNOSIS |
---|---|---|---|---|---|
GSM429903 | 37 | LN | negative | BL | DLBCL |
GSM429904 | 33 | lung | negative | GCB DLBCL | DLBCL |
GSM429905 | 46 | colon | positive | DLBCL_NC | DLBCL (PC) |
GSM429906 | not specified | Sm Bowel | negative | DLBCL_NC | High Grade, UC |
GSM429907 | not specified | LN | negative | BL | DLBCL |
GSM429908 | 33 | jejunum | positive | ABC DLBCL | DLBCL (PC) |
GSM429909 | 57 | Hilar/Lung | positive | DLBCL_NC | DLBCL |
GSM429910 | 32 | LN | positive | BL | High Grade, UC |
GSM4299 | 35 | colon | positive | GCB DLBCL | DLBCL |
GSM429912 | not specified | Hilar | positive | DLBCL_NC | DLBCL |
GSM429913 | 31 | Pleural Fluid | negative | ABC DLBCL | High Grade, UC |
GSM429914 | 24 | LN | positive | ABC DLBCL | DLBCL (PC) |
GSM429915 | 38 | Mediastinal/Atrial | negative | BL | DLBCL |
GSM429916 | 34 | neck | negative | GCB DLBCL | High Grade, UC |
GSM429917 | 43 | LN | positive | ABC DLBCL | DLBCL (PC) |
GSM429918 | not specified | LN | positive | ABC DLBCL | DLBCL (PC) |
GSM429919 | not specified | Spinal/Epidural | positive | ABC DLBCL | DLBCL (PC) |